| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.8 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.0063 | 0.8 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.9 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.9 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.9 |